利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

7 条记录 (耗时 0.044 秒)

    Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
    1.
    发明申请
    Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders 失效
    亚硝化和亚硝化化合物及其组合物及其用于治疗呼吸系统疾病的用途

    公开(公告)号：US20070155781A1

    公开(公告)日：2007-07-05

    申请号：US11604677

    申请日：2006-11-28

    申请人： David Garvey ,  L. Letts ,  H. Renfroe ,  Stewart Richardson

    发明人： David Garvey ,  L. Letts ,  H. Renfroe ,  Stewart Richardson

    IPC分类号： A61K31/46 ,  C07D451/02

    CPC分类号： C07D451/06 ,  C07C313/36 ,  C07D311/22 ,  C07D451/10 ,  C07D471/04 ,  C07J5/00 ,  C07J7/00 ,  C07J31/00 ,  C07J71/00 ,  C07J71/0031

    摘要： Disclosed are (i) compounds of a steroid, a β-agonist, an anticholinergic, a mast cell stabilizer and a phosphodiesterase (PDE) inhibitor directly or indirectly linked to a NO or NO2 group or a group which stimulates endogenous production of NO or EDRF in vivo; (ii) compositions of steroids, β-agonists, anticholinergics, mast cell stabilizers and PDE inhibitors, which can optionally be substituted with at least one NO or NO2 moiety or a group which stimulates endogenous production of NO or EDRF in vivo, and a compound that donates, transfers or releases nitric oxide as a charged species, i.e., nitrosonium (NO+) or nitroxyl (NO−), or as the neutral species, nitric oxide (NO.) or that stimulates endogenous production of NO or EDRF in vivo; and (iii) uses for them in preventing and/or treating respiratory disorders.

    摘要翻译： 公开的是（i）直接或间接连接到NO或NO 2基团或基团上的基团的类固醇，β-激动剂，抗胆碱能药，肥大细胞稳定剂和磷酸二酯酶（PDE）抑制剂的化合物 其在体内刺激NO或EDRF的内源性产生; （ii）类固醇，β-激动剂，抗胆碱能药物，肥大细胞稳定剂和PDE抑制剂的组合物，其可任选地被至少一个NO或NO 2个部分取代，或刺激内源性产生NO 或EDRF，以及作为带电物质，即亚硝酸盐（硝酸）或硝酰基（NO +）的一氧化氮，或NOX + 作为中性物种，一氧化氮（NO））或者在体内刺激NO或EDRF的内源性产生; 和（iii）用于预防和/或治疗呼吸系统疾病。

    Cyclooxygenase-2 selective inhibitors, compositions and methods of use
    3.
    发明申请
    Cyclooxygenase-2 selective inhibitors, compositions and methods of use 审中-公开
    环氧合酶-2选择性抑制剂，组合物和使用方法

    公开(公告)号：US20070238735A1

    公开(公告)日：2007-10-11

    申请号：US11802161

    申请日：2007-05-21

    申请人： David Garvey ,  Subhash Khanapure ,  Ramani Ranatunge ,  Stewart Richardson ,  Joseph Schroeder

    发明人： David Garvey ,  Subhash Khanapure ,  Ramani Ranatunge ,  Stewart Richardson ,  Joseph Schroeder

    IPC分类号： A61K31/495 ,  A61K31/415 ,  C07D213/00 ,  C07D241/10

    CPC分类号： C07D213/55 ,  C07D213/50 ,  C07D231/12 ,  C07D231/14

    摘要： The invention provides novel cyclooxygenase 2 (COX-2) selective inhibitors and novel compositions and kits comprising at least one cyclooxygenase 2 (COX-2) selective inhibitor, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The novel cyclooxygenase 2 selective inhibitors of the invention can be optionally nitrosated and/or nitrosylated. The invention also provides methods for treating inflammation, pain and fever; for treating and/or improving the gastrointestinal properties of COX-2 selective inhibitors; for facilitating wound healing; for treating and/or preventing renal and/or respiratory toxicity; for treating and/or preventing other disorders resulting from elevated levels of cyclooxygenase-2; and for improving the cardiovascular profile of COX-2 selective inhibitors.

    摘要翻译： 本发明提供新型环氧合酶2（COX-2）选择性抑制剂和包含至少一种环加氧酶2（COX-2）选择性抑制剂的新型组合物和试剂盒，以及任选地，至少一种捐赠，转移或释放一氧化氮的化合物， 内源性合成一氧化氮，提高内源性内源性松弛因子水平，或是一氧化氮合成酶的底物和/或至少一种治疗剂。 本发明的新型环加氧酶2选择性抑制剂可以任选地亚硝化和/或亚硝化。 本发明还提供了治疗炎症，疼痛和发烧的方法; 用于治疗和/或改善COX-2选择性抑制剂的胃肠性质; 促进伤口愈合; 用于治疗和/或预防肾和/或呼吸毒性; 用于治疗和/或预防由环氧合酶-2水平升高引起的其他疾病; 并用于改善COX-2选择性抑制剂的心血管外形。

    Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
    4.
    发明申请
    Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use 审中-公开
    含有亚硝基化和/或亚硝基化的环氧合酶-2选择性抑制剂的肟和/或腙，组合物和使用方法

    公开(公告)号：US20070155734A1

    公开(公告)日：2007-07-05

    申请号：US11705773

    申请日：2007-02-14

    申请人： Ramani Ranatunge ,  David Garvey ,  Stewart Richardson

    发明人： Ramani Ranatunge ,  David Garvey ,  Stewart Richardson

    IPC分类号： A61K31/541 ,  A61K31/5377 ,  A61K31/496 ,  A61K31/655 ,  A61K31/55 ,  A61K31/454 ,  A61K31/4196 ,  A61K31/4192 ,  A61K31/4164 ,  A61K31/415

    CPC分类号： C07D231/12

    摘要： The invention provides novel cyclooxygenase 2 (COX-2) selective inhibitors having at least one oxime group or hydrazone group and novel compositions and kits comprising at least one COX-2 selective inhibitor having at least one oxime group or hydrazone group, optionally nitrosated and/or nitrosylated, and, optionally, at least one nitric oxide donor, and/or, optionally, at least one therapeutic agent. The novel cyclooxygenase 2 selective inhibitors of the invention having at least one oxime group or hydrazone group can be optionally nitrosated and/or nitrosylated. The invention also provides methods for treating inflammation, pain and fever; for treating and/or improving the gastrointestinal properties of COX-2 selective inhibitors; for facilitating wound healing; for treating and/or preventing renal and/or respiratory toxicity; for treating and/or preventing other disorders resulting from elevated levels of cyclooxygenase-2; and for improving the cardiovascular profile of COX-2 selective inhibitors.

    摘要翻译： 本发明提供具有至少一个肟基或腙基团的新型环加氧酶2（COX-2）选择性抑制剂，以及包含至少一种具有至少一个肟基或腙基团的COX-2选择性抑制剂的新组合物和试剂盒，任选地亚硝化和/ 或亚硝酰化，和任选地至少一种一氧化氮供体，和/或任选的至少一种治疗剂。 具有至少一个肟基或腙基团的本发明的新型环加氧酶2选择性抑制剂可任选被亚硝化和/或亚硝化。 本发明还提供了治疗炎症，疼痛和发烧的方法; 用于治疗和/或改善COX-2选择性抑制剂的胃肠性质; 促进伤口愈合; 用于治疗和/或预防肾和/或呼吸毒性; 用于治疗和/或预防由环氧合酶-2水平升高引起的其他疾病; 并用于改善COX-2选择性抑制剂的心血管外形。

    Cyclooxygenase-2 selective inhibitors, compositions and methods of use
    5.
    发明申请
    Cyclooxygenase-2 selective inhibitors, compositions and methods of use 失效
    环氧合酶-2选择性抑制剂，组合物和使用方法

    公开(公告)号：US20060194861A1

    公开(公告)日：2006-08-31

    申请号：US11418187

    申请日：2006-05-05

    申请人： Ipul Bandarage ,  Richard Earl ,  Maiko Ezawa ,  Xinqin Fang ,  David Garvey ,  Subhash Khanapure ,  Ramani Ranatunge ,  Stewart Richardson ,  Joseph Schroeder ,  Cheri Stevenson ,  Shiow-Jyi Wey

    发明人： Ipul Bandarage ,  Richard Earl ,  Maiko Ezawa ,  Xinqin Fang ,  David Garvey ,  Subhash Khanapure ,  Ramani Ranatunge ,  Stewart Richardson ,  Joseph Schroeder ,  Cheri Stevenson ,  Shiow-Jyi Wey

    IPC分类号： C07D231/06 ,  A61K31/415

    CPC分类号： C07D231/12 ,  C07D261/08 ,  C07D401/04

    摘要： The invention describes novel cyclooxygenase 2 (COX-2) selective inhibitors and novel compositions comprising at least one cyclooxygenase 2 (COX-2) selective inhibitor, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The invention also provides novel kits comprising at least one COX-2 selective inhibitor, optionally nitrosated and/or nitrosylated, and, optionally, at least one nitric oxide donor, and/or, optionally, at least one therapeutic agent. The novel cyclooxygenase 2 selective inhibitors of the invention can be optionally nitrosated and/or nitrosylated. The invention also provides methods for treating inflammation, pain and fever; for treating and/or improving the gastrointestinal properties of COX-2 selective inhibitors; for facilitating wound healing; for treating and/or preventing renal and/or respiratory toxicity; for treating and/or preventing other disorders resulting from elevated levels of cyclooxygenase-2; and for improving the cardiovascular profile of COX-2 selective inhibitors.

    摘要翻译： 本发明描述了新型环氧合酶2（COX-2）选择性抑制剂和包含至少一种环氧合酶2（COX-2）选择性抑制剂的新型组合物，以及任选地至少一种捐赠，转移或释放一氧化氮的化合物，刺激内源性合成 的一氧化氮，提高内源性内源性释放因子水平，或者是一氧化氮合酶的底物和/或至少一种治疗剂。 本发明还提供了包含至少一种COX-2选择性抑制剂，任选地亚硝基化和/或亚硝基化的新的试剂盒，以及任选的至少一种一氧化氮供体，和/或任选的至少一种治疗剂。 本发明的新型环加氧酶2选择性抑制剂可以任选地亚硝化和/或亚硝化。 本发明还提供了治疗炎症，疼痛和发烧的方法; 用于治疗和/或改善COX-2选择性抑制剂的胃肠性质; 促进伤口愈合; 用于治疗和/或预防肾和/或呼吸毒性; 用于治疗和/或预防由环氧合酶-2水平升高引起的其他疾病; 并用于改善COX-2选择性抑制剂的心血管外形。

    Nitrosated and nitrosylated compounds, compositions and methods use
    6.
    发明申请
    Nitrosated and nitrosylated compounds, compositions and methods use 审中-公开
    亚硝化和亚硝化化合物，组合物和方法用途

    公开(公告)号：US20060009431A1

    公开(公告)日：2006-01-12

    申请号：US11221901

    申请日：2005-09-09

    申请人： Richard Earl ,  David Garvey ,  Ricky Gaston ,  Chia-En Lin ,  Ramani Ranatunge ,  Stewart Richardson ,  Cheri Stevenson

    发明人： Richard Earl ,  David Garvey ,  Ricky Gaston ,  Chia-En Lin ,  Ramani Ranatunge ,  Stewart Richardson ,  Cheri Stevenson

    IPC分类号： A61K31/56 ,  A61K31/21

    CPC分类号： C07J17/00 ,  C07J1/00 ,  C07J31/006 ,  C07J41/0044 ,  C07J43/00 ,  C07J43/003

    摘要： The invention describes novel nitrosated and/or nitrosylated compounds of the invention, and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitrosated and/or nitrosylated compound of the invention, and, optionally, at least one nitric oxide donor compound and/or at least one therapeutic agent. The invention also provides novel compositions comprising at least one compound of the invention, that is optionally nitrosated and/or nitrosylated, and at least one nitric oxide donor compound and/or at least one therapeutic agent. The compounds and compositions of the invention can also be bound to a matrix. The invention also provides methods for treating cardiovascular diseases, for inhibiting platelet aggregation and platelet adhesion caused by the exposure of blood to a medical device, for treating pathological conditions resulting from abnormal cell proliferation; transplantation rejections, autoimmune, inflammatory, proliferative, hyperproliferative or vascular diseases; for reducing scar tissue or for inhibiting wound contraction, particularly the prophylactic and/or therapeutic treatment of restenosis by administering at least one compound of the invention that is optionally nitrosated and/or nitrosylated, in combination with nitric oxide donors that are capable of releasing nitric oxide or indirectly delivering or transferring nitric oxide to targeted sites under physiological conditions. The compounds of the invention are preferably estradiol compounds, troglitazone compounds, tranilast compounds, retinoic acid compounds, resveratol compounds, myophenolic acid compounds, acid compounds, anthracenone compounds and trapidil compounds.

    摘要翻译： 本发明描述了本发明的新型亚硝化和/或亚硝基化化合物及其药学上可接受的盐，以及包含至少一种本发明的亚硝基化和/或亚硝化化合物和任选的至少一种一氧化氮供体化合物和/ 或至少一种治疗剂。 本发明还提供了包含至少一种本发明的化合物，其任选被亚硝化和/或亚硝基化的新化合物，以及至少一种一氧化氮供体化合物和/或至少一种治疗剂。 本发明的化合物和组合物也可以结合到基质上。 本发明还提供了治疗心血管疾病的方法，用于抑制由血液暴露于医疗器械引起的血小板聚集和血小板粘附，用于治疗由异常细胞增殖引起的病理状况; 移植排斥，自身免疫，炎症，增殖，过度增生或血管疾病; 用于减少瘢痕组织或抑制伤口收缩，特别是预防和/或治疗再狭窄的方法，通过给予至少一种任选地亚硝化和/或亚硝基化的本发明化合物与能够释放硝酸的一氧化氮供体组合 在生理条件下氧化或间接地将一氧化氮递送或转移到靶位点。 本发明的化合物优选为雌二醇化合物，曲格列酮化合物，曲尼司特化合物，视黄酸化合物，白藜芦醇化合物，肌醇酸化合物，酸化合物，蒽酮化合物和捕获剂化合物。